Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- befree-2016 importedOn "2016-02-19" NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_assertion wasGeneratedBy ECO_0000203 NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_assertion wasDerivedFrom befree-2016 NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_assertion SIO_000772 21243324 NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_assertion evidence source_evidence_literature NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.
- NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_assertion description "[High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865953.RADDaa5lFi8wKFXt6q5HWdfFHBIESh_5dPm1dj_BN1bS0130_provenance.